![]() Data integrity can further suffer from inaccuracy, incompleteness, and a lack of standardization across multiple providers and institutions. Difficulties can arise from the fact that administrative data are not collected for the purpose of defining research cohorts. However, even with multiple available coding systems, identifying patients in a target cohort can be challenging. Exposures and outcomes based on EHR data are often defined by administrative code data, such as the Current Procedural Terminology (CPT) codes and International Classification of Disease (ICD) codes. Epub 3.Anticipated benefits of the electronic health record (EHR) included the ability to use existing patient data to rapidly answer research questions and provide accurate quality metrics. Predictive factors for malignant pheochromocytoma: analysis of 136 patients. Epub 8.įeng F, Zhu Y, Wang X, Wu Y, Zhou W, Jin X, et al. Predictive characteristics of malignant pheochromocytoma. Park J, Song C, Park M, Yoo S, Park SJ, Hong S, et al. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center. Szalat A, Fraenkel M, Doviner V, Salmon A, Gross DJ. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. Malignant pheochromocytoma: new malignancy criteria. Epub 0.ĭe Wailly P, Oragano L, Rade F, Beaulieu A, Arnault V, Levillain P, et al. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Epub 9.Įisenhofer G, Tischler AS, de Krijger RR. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG. Epub 4.įishbein L, Bonner L, Torigian DA, Nathanson KL, Cohen DL, Pryma D, et al. ![]() Imaging characterization of benign and malignant pheochromocytoma or paraganglioma: comparison between MIBG uptake and MR signal intensity ratio. Maurea S, Cuocolo A, Imbriaco M, Pellegrino T, Fusari M, Cuocolo R, et al. Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma. Nakano S, Tsushima Y, Higuchi T, Taketomi-Takahashi A, Amanuma M. Sunitinib treatment for refractory malignant pheochromocytoma. Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. Parenti G, Zampetti B, Rapizzi E, Ercolino T, Giache V, Mannelli M. American journal of physiology Endocrinology and metabolism. Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. Saito Y, Tanaka Y, Aita Y, Ishii KA, Ikeda T, Isobe K, et al. Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma. Sun FK, He HC, Su TW, Zhou WL, Huang X, Dai J, et al. Pain practice : the official journal of World Institute of Pain. Malignant pheochromocytoma presenting as incapacitating bony pain. Die operative Therapie einer polytopen Wirbelsaulenmetastasierung bei malignem Phaochromocytom. Zeitschrift fur Orthopadie und ihre Grenzgebiete. Cervical spine metastasis from adrenal pheochromocytoma. Kheir E, Pal D, Mohanlal P, Shivane A, Chakrabarty A, Timothy J. A propos d'un cas de pheochromocytome malin avec invasion vertebrale. Pheochromocytome et problemes de malignite. Archives of orthopaedic and trauma surgery. Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma. Yoshida S, Hatori M, Noshiro T, Kimura N, Kokubun S. Okuyama A, Takahara S, Nakamura M, Oka T, Tada Y, Namiki M, et al. Mukai M, Kanno N, Nakagawa M, Uemura M, Nishimura K, Miyoshi S, et al. Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging. Lynn MD, Braunstein EM, Wahl RL, Shapiro B, Gross MD, Rabbani R. Epub 1.Ĭuerda C, Castejon I, Astigarraga B, Blanco C, Lucas T, Barcelo B, et al.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |